Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 44 for “"Nintedanib"”.

  1. COMBINATORIAL TARGETED THERAPY OF MAB AND NINTEDANIB ENHANCES CANCER CELL LETHALITY

    … itself as a potential anti-cancer strategy. With Nintedanib identified as an EMT-reversing agent, coupled with being an FDA-approved triple angiokinase inhibitor, makes it a promising drug whose utility can further be broadened. Using a two-pronged combinatory approach with ovarian cancer as a …

    nus Repository record for COMBINATORIAL TARGETED THERAPY OF MAB AND NINTEDANIB ENHANCES CANCER CELL LETHALITY (opens in a new tab) Download file for COMBINATORIAL TARGETED THERAPY OF MAB AND NINTEDANIB ENHANCES CANCER CELL LETHALITY (opens in a new tab)

  2. Regulation of the intestinal smooth muscle cell phenotype by the antifibrotic drug nintedanib

    … of a multimodal tyrosine kinase inhibitor, nintedanib (NIND), which was recently approved for idiopathic pulmonary fibrosis (IPF), a chronic and fatal lung condition resembling CD. High-passage adult rat ISMC were used in vitro as a model system to study the growth and phenotypic changes …

    queens Repository record for Regulation of the intestinal smooth muscle cell phenotype by the antifibrotic drug nintedanib (opens in a new tab)

  3. Nintedanib: A New Hope for Patients with Systemic Sclerosis-Associated Interstitial Lung Disease

    … by the decline in forced vital capacity. Nintedanib (NIN) is a promising antifibrotic treatment that is FDA approved to treat SSc-ILD. This is a literature review in which three studies were selected to investigate the effectiveness and safety of NIN in comparison to an impactful precursor …

    oregon Repository record for Nintedanib: A New Hope for Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (opens in a new tab)

  4. Anti-fibrotic effects of Nintedanib and Pirfenidone on alveolar epithelial cell function in ex-vivo 3D-Lung Tissue Cultures

    … drugs known to slow disease progression are Nintedanib and Pirfenidone. However, the life expectancy is still limited with or without treatment. Therefore, novel therapeutic options are needed. In this context, a more in- depth understanding of the mechanism of action of Nintedanib and …

    lmu-germany Repository record for Anti-fibrotic effects of Nintedanib and Pirfenidone on alveolar epithelial cell function in ex-vivo 3D-Lung Tissue Cultures (opens in a new tab)

  5. Dry powder for inhalation of single and fixed dose combinations of nintedanib, pirfenidone and mycophenolic acid prepared by thin-film freezing technology

    … found that the TFF process produces inhaled nintedanib powder with high aerodynamic performance. Moreover, the process parameters, including drug loading and excipients, can affect physical properties and aerodynamic performance. The brittle-matrix characters of the TFF powders, including …

    texas Repository record for Dry powder for inhalation of single and fixed dose combinations of nintedanib, pirfenidone and mycophenolic acid prepared by thin-film freezing technology (opens in a new tab)

  6. Tyrosinkinaseinhibitoren in der Therapie des oralen Plattenepithelkarzinoms – In vitro Evaluation zur Wirksamkeit von Afatinib, Volasertib und Nintedanib in Kombination mit Cisplatin und SMAC-Mimetics

    … zur Anwendung der TKI Afatinib, Volasertib und Nintedanib in alleiniger Anwendung sowie Kombinationstherapie mit Cisplatin und dem Smac-mimetic LCL-161. Die Analyse der Wirksamkeit oben genannter Stoffe erfolgte durch eine In-vitro-Evaluation an fünf Zelllinien des humanen …

    wurz-thes Repository record for Tyrosinkinaseinhibitoren in der Therapie des oralen Plattenepithelkarzinoms – In vitro Evaluation zur Wirksamkeit von Afatinib, Volasertib und Nintedanib in Kombination mit Cisplatin und SMAC-Mimetics (opens in a new tab)

  7. Which factors predict early discontinuation of antifibrotics in idiopathic pulmonary fibrosis?

    Introduction: Pirfenidone and nintedanib are recommended in idiopathic pulmonary fibrosis (IPF). Randomised controlled trials have shown discontinuation rates of 14-33%; clinical audit in our regional centre showed a rate of 18.4%. I aimed to establish the main factors, which predict early …

    birmingham Download PDF for Which factors predict early discontinuation of antifibrotics in idiopathic pulmonary fibrosis? (opens in a new tab)

  8. Biologic and Therapeutic Studies to Improve the Anti-tumor Efficacy of Antiangiogenic Tyrosine Kinase Inhibitors

    … study involving two antiangiogenic TKIs (nintedanib, sunitinib), the VEGFR2 antibody DC101, and one chemotherapeutic drug (paclitaxel), I evaluated whether such failures may be related in part to the inability of TKIs to inhibit chemotherapy-induced pro-tumorigenic, host responses, which …

    toronto-retro Repository record for Biologic and Therapeutic Studies to Improve the Anti-tumor Efficacy of Antiangiogenic Tyrosine Kinase Inhibitors (opens in a new tab)

  9. Antifibrotics for Cleft Palate Muscle Repair

    … focusing on two antifibrotic approaches: Nintedanib and several TGF-β receptor I inhibitors. In vitro, these drugs effectively blocked myofibroblast formation and enhanced muscle cell growth. In rats, however, systemic Nintedanib caused side effects and did not prevent long-term scarring. …

    radboud Repository record for Antifibrotics for Cleft Palate Muscle Repair (opens in a new tab) Download PDF for Antifibrotics for Cleft Palate Muscle Repair (opens in a new tab)

  10. Idiopathic pulmonary fibrosis: pathogenesis, progression, treatments, and future prospects

    … response to trigger the pathogenesis of IPF. Nintedanib, a potent tyrosine kinase receptor inhibitor was first developed in 1998 as a candidate for cancer treatment. Investigation of its effects in fibrosis in the past few decades has led to a significant discovery of its application in IPF. …

    bu Repository record for Idiopathic pulmonary fibrosis: pathogenesis, progression, treatments, and future prospects (opens in a new tab)

  11. The role of telomeres in pulmonary fibrosis and its effects on choices of treatment

    … prednisone, azathioprine, pirfenidone, nintedanib (with and without statins), and low-dose inhaled carbon monoxide. The treatment options with the favored positive results are danazol and nintedanib.

    bu Repository record for The role of telomeres in pulmonary fibrosis and its effects on choices of treatment (opens in a new tab)

  12. Developing a Fibrotic Phenotype in a 3D Human Skeletal Muscle Microphysiological System

    … contractile force. Testing anti-fibrotic drug Nintedanib in this model, showed an increase in tetanus force production in 2 out of 3 donors and reduction of pro-fibrotic ECM accumulation of collagen 1 and fibronectin. Western blot analysis of Nintedanib also providence evidence of its …

    duke Repository record for Developing a Fibrotic Phenotype in a 3D Human Skeletal Muscle Microphysiological System (opens in a new tab)

  13. Idiopatinė plaučių fibrozė. Literatūros apžvalga ir klinikinis atvejis /

    … of patients, and the antifibrotic drugs nintedanib and pirfenidone only delay the progress of the disease. It is recommended to test liver transaminase activity and bilirubin levels before prescribing antifibrotic drugs and to monitor them at regular intervals during treatment. This …

    vilnius Repository record for Idiopatinė plaučių fibrozė. Literatūros apžvalga ir klinikinis atvejis / (opens in a new tab)

  14. Discovery, characterization, and application of novel MELK inhibitors to investigate the role of MELK in triple negative breast cancer

    … identification of an indolinone core molecule, nintedanib, as a lead compound through a kinase inhibitor cross-screening. Further elaboration of the scaffold produces derivatives with subnanomolar potency towards MELK and preliminary selectivity against original tyrosine kinase targets of …

    texas Repository record for Discovery, characterization, and application of novel MELK inhibitors to investigate the role of MELK in triple negative breast cancer (opens in a new tab)

  15. The Genetic Epidemiology of Complex Lung Diseases

    … potential mechanisms by which pirfenidone and nintedanib attenuate fibrosis by performing an integrative ‘omics analysis of transcriptomics and proteomic responses to TGFb1-stimulated lung fibroblasts; 2) define a skeletal muscle fiber shift phenotype in both males and females with COPD and …

    uab Repository record for The Genetic Epidemiology of Complex Lung Diseases (opens in a new tab)

  16. Integrative Analysis of Acute and Chronic In Vivo Fibrosing Interstitial Lung Disease Using Image- and Molecular-Based Omics Approaches

    … stratify the degree of antifibrotic response to nintedanib in (experimental) fibrosing ILD. Importantly, the established radioproteomic signatures paralleled disease- and drug-specific biological pathway activity with high specificity, including extracellular matrix remodeling, cell cycle …

    zurich

  17. Development of Fibrotic Micro-Tissue Model for Predicting Anti-Fibrosis Drug Efficacy

    … therapeutic efficacy of two anti-fibrosis drugs; Nintedanib and Pirfenidone. The capability of this novel platform is also tested by coupling the microtissue array with cyclic stretching system to simulate breathing and testing the effect of the mentioned drugs on biomechanical properties of …

    buffalo Repository record for Development of Fibrotic Micro-Tissue Model for Predicting Anti-Fibrosis Drug Efficacy (opens in a new tab)

  18. EVALUATING THE ABILITY OF β-GLUCAN AND RP-182 DERIVED NANOPARTICLES TO MODULATE MACROPHAGES AS POTENTIAL LUNG FIBROSIS THERAPEUTICS

    … lungs. Current therapies include Pirfenidone and Nintedanib, which slow but do not stop disease progression, underscoring the need for new treatment strategies. Macrophages are central regulators of tissue homeostasis, immunity, and repair. In the fibrotic lung, they become aberrantly activated …

    mcmaster Repository record for EVALUATING THE ABILITY OF β-GLUCAN AND RP-182 DERIVED NANOPARTICLES TO MODULATE MACROPHAGES AS POTENTIAL LUNG FIBROSIS THERAPEUTICS (opens in a new tab)

  19. Difunctionalizations of Alkynes in the Domino Synthesis of Heterocycles

    … of derivatizations, including the synthesis of nintedanib. Isomerization and halide-exchange experiments were performed to gain further insight into the reaction mechanism. Furthermore, analogous reactivity was extended towards the synthesis of chlorinated methylene pyrrolidones and …

    toronto-retro Repository record for Difunctionalizations of Alkynes in the Domino Synthesis of Heterocycles (opens in a new tab)

  20. Thiazolidinone-isatin hybrids as multi-target anticancer agents

    … kinase inhibitors, including Sunitinib and Nintedanib, the second project aims to the design and synthesis of indolinone derivates able to inhibit different kinases. In this respect, I have been visiting researcher at the University College Cork, in Ireland, under the supervision of Dr. …

    cagliari Repository record for Thiazolidinone-isatin hybrids as multi-target anticancer agents (opens in a new tab)

Page 1 of 3